Stock Quality:
Last 7 days
0.7%
Last 30 days
-4.8%
Last 90 days
-11.2%
Trailing 12 Months
-29.5%
CRSP RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 287.7M | 204.3M | 120.8M | 37.3M |
2023 | 0 | 0 | 0 | 371.2M |
2022 | 0 | 0 | 0 | 0 |
2021 | 646.9M | 736.3M | 825.6M | 915.0M |
2020 | 0 | 378.9M | 468.3M | 557.6M |
2019 | 2.1M | 97.9M | 193.8M | 289.6M |
2018 | 31.5M | 22.1M | 12.6M | 3.1M |
2017 | 7.4M | 10.2M | 11.0M | 41.0M |
2016 | 1.2M | 2.1M | 3.1M | 5.2M |
2015 | 0 | 0 | 0 | 247.0K |
CEO | Dr. Samarth Kulkarni Ph.D. |
---|---|
WEBSITE | crisprtx.com |
SECTOR | Healthcare |
INDUSTRY | Biotechnology |
EMPLOYEES | 458 |